Annual Drug Patent Expirations for LEXISCAN
Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug and one Paragraph IV challenge.
This drug has eigthy-one patent family members in twenty-six countries.
Copyright © DrugPatentWatch. Originally published at Patent delisted for Astellas drug LEXISCAN